{
    "2019-08-08": [
        [
            {
                "time": "",
                "original_text": "同仁堂国药（03613.HK）中期纯利同比增17%，机构怎样看待后市？",
                "features": {
                    "keywords": [
                        "同仁堂国药",
                        "中期纯利",
                        "同比增17%"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "北京同仁堂一中医医院再出事 “蜂蜜门”事件之后仍屡曝问题",
                "features": {
                    "keywords": [
                        "北京同仁堂",
                        "中医医院",
                        "蜂蜜门",
                        "屡曝问题"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}